Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin)

• Catalog Number: orb1818397
• Category: Antibodies
• Description: Recombinant Antibody
• Clonality: Monoclonal
• Tested applications: ELISA, FC
• Reactivity: Human
• Isotype: IgG1
• Antibody Type: Primary Antibody
• Concentration: 1mg/ml
• Form/Appearance: Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column.
• Conjugation: Unconjugated
• MW: 145.48
• UniProt ID: P28908
• Protein Sequence: TNFRSF8 / CD30
• Expression System: CHO Cell
• Endotoxins: < 0.001EU/μg,determined by LAL method.
• Alternative names: Tumor necrosis factor receptor superfamily member
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

The purity of Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin) is more than 98.99%, determined by SEC-HPLC.

Immobilized human CD30 His at 2 µg/mL can bind Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin), EC50=0.006007 µg/mL

Anti-TNFRSF8 / CD30 Reference Antibody (brentuximab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%